Comparative immunogenicity of two bivalent botulinum vaccines

Area of Science:

• Veterinary immunology
• Bovine health
• Vaccinology

Background:

• Clostridium botulinum types C and D cause significant disease in cattle in Northern Australia.
• Effective vaccination strategies are crucial for preventing botulism in cattle.
• Evaluating novel vaccine formulations is essential for improving herd immunity.

Purpose of the Study:

• To compare the immunogenicity of a new single-dose botulinum vaccine (Websters Singvac) with a conventional vaccine.
• To assess antibody production against Clostridium botulinum types C and D in cattle.
• To evaluate vaccine efficacy in the specific context of Northern Australia.

Main Methods:

• A randomized study involving 150 Brahman steer weaners.
• Administration of a single dose of either CSL Bivalent Botulinum vaccine or Websters Singvac.
• Collection of blood samples at 0, 8, and 24 weeks post-vaccination.
• Analysis of antibody levels using ELISA and toxin neutralization tests.

Main Results:

• Websters Singvac elicited a twofold higher ELISA antibody response compared to the conventional vaccine six months post-inoculation.
• This enhanced response was specific to neutralizing antibodies against type C botulinum toxin.
• Both vaccines demonstrated comparable efficacy in producing neutralizing antibodies against type D botulinum toxin.

Conclusions:

• Websters Singvac offers a superior single-dose vaccination strategy for type C botulism in cattle.
• The new vaccine provides equivalent protection against type D botulism compared to conventional products.
• These findings support the use of Websters Singvac for improved cattle health in regions endemic for botulism.